Vertex’s once-daily triple therapy approved for eligible patients aged six and over More: NHS England secures access to new cystic fibrosis treatment ALYFTREK Source: News
read more
Sebetralstat offers injection-free relief for patients aged 12 and over More: MHRA approves first oral treatment for hereditary angioedema attacks Source: News
read moreAlong with the CEO transition announcement, the company disclosed preliminary financial results showing a 4% sales slide during the second quarter. More: Consumer health giant Kenvue kicks off CEO transition as sales slip Source: fierce
read morePerrigo has agreed to sell its branded “dermacosmetics” business to Kairos Bidco—an investment vehicle overseen by private equity and investment firm KKR—for up to 327 million euros. The move aligns with a new strategy, dubbed the “Three-S’ Plan, that Perrigo
read moreAs GSK’s Blenrep makes its return to markets around the world, the company has big expectations for the antibody-drug conjugate. But FDA reviewers are taking a close look at safety data from two phase 3 trials. More: As GSK eyes
read moreAs Miami-based Veru continues development of its enobosarm to prevent muscle wasting in patients being treated for obesity, among other conditions, the biopharma has conducted a survey showing that the side effect looms large in the minds of GLP-1 users.
read more© 1994 - 2025 B.M. Pharmaceuticals